Papers: 10.1038/oncsis.2017.17

https://doi.org/10.1038/oncsis.2017.17

MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells

Cited by: 41
Author(s): Kristine Raaby Jakobsen, Christina Demuth, Anne Tranberg Madsen, Dianna Hussmann, Johan Vad-Nielsen, Anders Lade Nielsen, Boe Sandahl Sørensen
Published: over 9 years ago

Software Mentions 1